{"id":31954,"date":"2025-03-17T13:43:20","date_gmt":"2025-03-17T12:43:20","guid":{"rendered":"https:\/\/ggba.swiss\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/"},"modified":"2025-03-17T13:52:38","modified_gmt":"2025-03-17T12:52:38","slug":"perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/","title":{"rendered":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT"},"content":{"rendered":"\n<p>La Suisse occidentale continue de promouvoir l&rsquo;innovation de pointe dans les domaines de la sant\u00e9 et de la biotechnologie, les start-ups jouant un r\u00f4le crucial pour relever les principaux d\u00e9fis de l&rsquo;industrie. Des diagnostics de la vue bas\u00e9s sur l&rsquo;IA \u00e0 la production biopharmaceutique de nouvelle g\u00e9n\u00e9ration, en passant par les solutions num\u00e9riques pour le recrutement de personnel de sant\u00e9, les entreprises \u00e9mergentes d\u00e9veloppent des technologies transformatrices. Avec le soutien de la Fondation pour l&rsquo;innovation et la technologie (<a href=\"https:\/\/www.fondation-fit.ch\/\">FIT)<\/a>, ces start-ups acc\u00e9l\u00e8rent leur croissance, mettent sur le march\u00e9 des solutions \u00e0 fort impact et renforcent la position de la r\u00e9gion en tant que leader mondial de l&rsquo;innovation en mati\u00e8re de technologies de la sant\u00e9 et de biotechnologies.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">PeriVision : des tests de la vue bas\u00e9s sur l&rsquo;IA pour des diagnostics plus rapides<\/h4>\n\n\n\n<p>L&rsquo;ophtalmologie est confront\u00e9e \u00e0 des d\u00e9fis croissants, car les maladies oculaires li\u00e9es \u00e0 l&rsquo;\u00e2ge augmentent alors que le nombre de sp\u00e9cialistes reste insuffisant. Les tests de vision traditionnels sont longs, co\u00fbteux et sujets \u00e0 des inexactitudes, ce qui contribue \u00e0 retarder le diagnostic et le traitement.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.perivision.com\/\">PeriVision<\/a> a d\u00e9velopp\u00e9 un casque de r\u00e9alit\u00e9 virtuelle \u00e9quip\u00e9 d&rsquo;un logiciel bas\u00e9 sur l&rsquo;intelligence artificielle, qui permet d&rsquo;effectuer des tests de vision plus pr\u00e9cis en une fraction du temps. Le syst\u00e8me augmente le d\u00e9bit des patients de 30%, ce qui am\u00e9liore \u00e0 la fois le diagnostic et la d\u00e9tection pr\u00e9coce des maladies.<\/p>\n\n\n\n<p>Gr\u00e2ce \u00e0 un pr\u00eat Tech Growth de CHF 300&rsquo;000, PeriVision va \u00e9largir sa client\u00e8le et d\u00e9velopper de nouvelles fonctionnalit\u00e9s, notamment des algorithmes avanc\u00e9s de diagnostic et de pr\u00e9diction.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Bioscibex : transformer la production biopharmaceutique<\/h4>\n\n\n\n<p>Les produits biopharmaceutiques r\u00e9volutionnent les traitements du cancer et des maladies auto-immunes, mais les co\u00fbts de production \u00e9lev\u00e9s restent un obstacle \u00e0 leur accessibilit\u00e9. Le processus traditionnel de fabrication des m\u00e9dicaments est complexe et comporte sept \u00e9tapes s\u00e9quentielles qui font grimper les co\u00fbts et augmentent les risques de contamination.<\/p>\n\n\n\n<p><a href=\"https:\/\/bioscibex.com\/\">Bioscibex<\/a> a mis au point un bior\u00e9acteur innovant qui r\u00e9duit ces \u00e9tapes \u00e0 deux seulement, ce qui permet de r\u00e9duire consid\u00e9rablement les d\u00e9lais et les co\u00fbts de production. La technologie \u00e9volutive de l&rsquo;entreprise permet l&rsquo;expansion cellulaire de 30 ml \u00e0 30 l en un seul processus, ce qui en fait l&rsquo;un des bior\u00e9acteurs les plus efficaces du march\u00e9.<\/p>\n\n\n\n<p>Le pr\u00eat Tech Seed de CHF 100&rsquo;000 de la FIT soutiendra le d\u00e9veloppement d&rsquo;un prototype b\u00eata, qui devrait \u00eatre test\u00e9 par les clients d&rsquo;ici la mi-2025.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Carewell : une solution num\u00e9rique pour la crise du personnel de sant\u00e9 en Suisse<\/h4>\n\n\n\n<p>La Suisse conna\u00eet une grave p\u00e9nurie de professionnels de la sant\u00e9, avec 12&rsquo;000 postes vacants et un taux d&rsquo;absent\u00e9isme atteignant 20%. Parall\u00e8lement, plus de 60&rsquo;000 anciens professionnels de la sant\u00e9 restent en dehors du march\u00e9 du travail en raison d&rsquo;un manque de possibilit\u00e9s d&#8217;emploi flexibles.<\/p>\n\n\n\n<p>La plateforme num\u00e9rique de <a href=\"https:\/\/www.carewell.ch\/\">Carewell<\/a> comble cette lacune en mettant en relation les h\u00f4pitaux et les \u00e9tablissements de soins avec des professionnels qualifi\u00e9s \u00e0 la recherche de postes flexibles. Gr\u00e2ce \u00e0 un syst\u00e8me de mise en relation bas\u00e9 sur l&rsquo;IA, la plateforme rationalise le recrutement tout en am\u00e9liorant la r\u00e9tention du personnel et la satisfaction au travail.<\/p>\n\n\n\n<p>Apr\u00e8s une bourse de CHF 20&rsquo;000 en 2024, la FIT a accord\u00e9 un pr\u00eat Digital Seed de CHF 50&rsquo;000 pour aider Carewell \u00e0 d\u00e9velopper sa plateforme, \u00e0 renforcer ses efforts de marketing et \u00e0 recruter davantage de professionnels de sant\u00e9 ind\u00e9pendants. En soutenant PeriVision, Bioscibex et Carewell, la FIT renforce le r\u00f4le de leader de la Suisse occidentale dans le domaine de l&rsquo;innovation en mati\u00e8re de soins de sant\u00e9 et de biotechnologie. Ces start-ups sont appel\u00e9es \u00e0 am\u00e9liorer les diagnostics, \u00e0 r\u00e9duire les co\u00fbts de production des m\u00e9dicaments et \u00e0 rem\u00e9dier aux p\u00e9nuries de main-d&rsquo;\u0153uvre, contribuant ainsi \u00e0 un syst\u00e8me de sant\u00e9 plus efficace et plus accessible.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Fondation pour l&rsquo;innovation et la technologie (FIT) a accord\u00e9 un financement aux start-ups prometteuses de Suisse occidentale PeriVision, Bioscibex et Carewell, afin d&rsquo;acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9 et la biotechnologie.<\/p>\n","protected":false},"author":6,"featured_media":31950,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1169,1162,1148,1181,1163,1141],"class_list":["post-31954","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-biotech-fr-2","tag-education-en-fr","tag-financing-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT<\/title>\n<meta name=\"description\" content=\"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d&#039;acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT\" \/>\n<meta property=\"og:description\" content=\"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d&#039;acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T12:43:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-17T12:52:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT\",\"datePublished\":\"2025-03-17T12:43:20+00:00\",\"dateModified\":\"2025-03-17T12:52:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\"},\"wordCount\":694,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Biotech\",\"Education\",\"Financing\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\",\"name\":\"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"datePublished\":\"2025-03-17T12:43:20+00:00\",\"dateModified\":\"2025-03-17T12:52:38+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d'acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"PeriVision, Bioscibex et Carewell ont re\u00e7u un total de CHF 450'000 en pr\u00eats pour am\u00e9liorer leurs solutions innovantes dans les domaines du diagnostic visuel, de la production biopharmaceutique et du recrutement de personnel de sant\u00e9. | \u00a9 FIT\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT","description":"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d'acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/","og_locale":"fr_FR","og_type":"article","og_title":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT","og_description":"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d'acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.","og_url":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-03-17T12:43:20+00:00","article_modified_time":"2025-03-17T12:52:38+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT","datePublished":"2025-03-17T12:43:20+00:00","dateModified":"2025-03-17T12:52:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/"},"wordCount":694,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","keywords":["Artificial Intelligence","Biotech","Education","Financing","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/","url":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/","name":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","datePublished":"2025-03-17T12:43:20+00:00","dateModified":"2025-03-17T12:52:38+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La FIT a accord\u00e9 une bourse \u00e0 PeriVision, Bioscibex et Carewell, pour d'acc\u00e9l\u00e9rer leur d\u00e9veloppement dans les technologies de la sant\u00e9.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","width":1180,"height":811,"caption":"PeriVision, Bioscibex et Carewell ont re\u00e7u un total de CHF 450'000 en pr\u00eats pour am\u00e9liorer leurs solutions innovantes dans les domaines du diagnostic visuel, de la production biopharmaceutique et du recrutement de personnel de sant\u00e9. | \u00a9 FIT"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/perivision-bioscibex-et-carewell-recoivent-le-soutien-de-la-fit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"PeriVision, Bioscibex et Carewell re\u00e7oivent le soutien de la FIT"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=31954"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31954\/revisions"}],"predecessor-version":[{"id":31956,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31954\/revisions\/31956"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/31950"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=31954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=31954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=31954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}